DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Baldwin DS, Montgomery SA.
First clinical experience with olanzapine (LY 170053): Results of an open-label safety and dose-ranging study in patients with schizophrenia.
Int Clin Psychopharmacol 1995;
10: 239-44
We do not assume any responsibility for the contents of the web pages of other providers.